Sarepta shares plunge 30% as future of its gene therapy appears at risk

cnbc.com/2025/07/18/sarepta-stock-falls-on-fda-gene-therapy-elevidys-comment.html

Sarepta reported a third death tied to its gene therapies.

This story appeared on cnbc.com, 2025-07-18 17:19:42.
The Entire Business World on a Single Page. Free to Use →